Core Insights - The meeting focuses on the Vascular Intervention business acquired from BIOTRONIK on June 30 of this year, highlighting growth opportunities for Teleflex's Interventional business [2][3]. Group 1 - The call is led by key executives from Teleflex, including the Chairman, President, and CEO, indicating the importance of the Vascular Intervention business to the company's strategy [4]. - Slides accompanying the call are available on the company's website, providing additional context and information for investors [2][3]. - The company aims to provide a deeper understanding of the acquired Vascular Intervention portfolio and its future opportunities for investors [3].

Conference Call Logistics Teleflex Incorporated Third Quarter 2025 Earnings Conference Call 11/6/2025 The release, accompanying slides, and replay webcast are available online at www.teleflex.com (click on Investors) An audio replay of the call will be available beginning at 11:00 am Eastern Time on November 6, 2025 either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S.) or 1 609 800 9909 (all other locations). The confirmation code is 69028. Today's Speaker ...